BCACP Cardiovascular Risk Reduction 2

Question 1

A 58-year-old patient with hypertension and CKD (eGFR 35 mL/min) needs antihypertensive therapy. Which agent provides both BP control and renoprotection?

Accepted Answer

ACE inhibitor

Answer

ACE inhibitors reduce intraglomerular pressure and proteinuria, providing renoprotection in CKD patients with hypertension.

Question 2

According to ACC/AHA guidelines, which 10-year ASCVD risk threshold defines high risk and warrants statin initiation in primary prevention?

Accepted Answer

≥7.5%

Answer

A 10-year ASCVD risk ≥7.5% is the threshold for considering statin therapy in primary prevention per ACC/AHA guidelines.

Question 3

A patient on warfarin for atrial fibrillation has a subtherapeutic INR of 1.5. Which dietary change most likely contributed?

Accepted Answer

Increased green leafy vegetable intake

Answer

Green leafy vegetables are high in vitamin K, which antagonizes warfarin's anticoagulant effect and lowers the INR.

Question 4

Which class of medications is preferred for secondary prevention after a myocardial infarction to reduce mortality?

Accepted Answer

Beta-blockers

Answer

Beta-blockers reduce mortality after MI by decreasing myocardial oxygen demand, preventing arrhythmias, and reducing reinfarction risk.

Question 5

A 65-year-old male with diabetes and hypertension has a urine albumin-to-creatinine ratio of 450 mg/g. Which agent is MOST appropriate to add?

Accepted Answer

Dapagliflozin

Answer

SGLT2 inhibitors like dapagliflozin have demonstrated cardiorenal protective benefits including reduction of albuminuria and CKD progression.

BCACP - Board Certified Ambulatory Care Pharmacist Exam Practice Test

BCACP - Board Certified Ambulatory Care Pharmacist Exam Practice Test

BCACP Cardiovascular Risk Reduction 2